Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Aurinia Pharmaceuticals (AUPH)
Technical Analysis Report for USA stock AUPH Aurinia Pharmaceuticals. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AUPH Aurinia Pharmaceuticals then click here. or read Experts views on Aurinia Pharmaceuticals or Forecast & share price targets of Aurinia Pharmaceuticals
Aurinia Pharmaceuticals Opened at 14.26 and Closed at: 14.44, which is 1.25% of previous session's close. It moved within a range of 14.20 and 14.54
The session was a Bullish session with an average volume of 886600, which is -0.47% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 14.32 and resistance for tomorrow is 14.66
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 14.25, 14.05 resistance for tomorrow's hourly charts is 14.59, 14.73
10 Day SMA for Aurinia Pharmaceuticals (AUPH) is 14.67 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Aurinia Pharmaceuticals (AUPH) is 14.8 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Aurinia Pharmaceuticals (AUPH) is 15.41 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 14.18 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Aurinia Pharmaceuticals is 11.8 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Aurinia Pharmaceuticals is at 14.8 and 200 DMA is at 11.8, while 50 DMA and 100 DMA are at 15.41 and 14.18 respectively
Aurinia Pharmaceuticals (AUPH) moving average of 20 SMA is at 14.8 and 20 EMA is at 14.85
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 14.44 | 14.8 | 14.85 |
| 05 Thu Feb | 14.26 | 14.85 | 14.89 |
| 04 Wed Feb | 14.58 | 14.94 | 14.96 |
| 03 Tue Feb | 15.21 | 14.98 | 15 |
| 02 Mon Feb | 15.22 | 14.98 | 14.98 |
| 30 Fri Jan | 14.53 | 14.99 | 14.96 |
Aurinia Pharmaceuticals (AUPH) moving average of 50 SMA is at 15.41 and 50 EMA is at 14.9
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 14.44 | 15.41 | 14.9 |
| 05 Thu Feb | 14.26 | 15.45 | 14.92 |
| 04 Wed Feb | 14.58 | 15.48 | 14.95 |
| 03 Tue Feb | 15.21 | 15.49 | 14.96 |
| 02 Mon Feb | 15.22 | 15.49 | 14.95 |
| 30 Fri Jan | 14.53 | 15.49 | 14.94 |
Aurinia Pharmaceuticals (AUPH) moving average of 100 SMA is at 14.18 and 100 EMA is at 14.12
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 14.44 | 14.18 | 14.12 |
| 05 Thu Feb | 14.26 | 14.17 | 14.11 |
| 04 Wed Feb | 14.58 | 14.15 | 14.11 |
| 03 Tue Feb | 15.21 | 14.13 | 14.1 |
| 02 Mon Feb | 15.22 | 14.1 | 14.08 |
| 30 Fri Jan | 14.53 | 14.08 | 14.06 |
Aurinia Pharmaceuticals (AUPH) moving average of 200 SMA is at 11.8 and 200 EMA is at 12.52
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 14.44 | 11.8 | 12.52 |
| 05 Thu Feb | 14.26 | 11.77 | 12.5 |
| 04 Wed Feb | 14.58 | 11.74 | 12.48 |
| 03 Tue Feb | 15.21 | 11.7 | 12.46 |
| 02 Mon Feb | 15.22 | 11.67 | 12.43 |
| 30 Fri Jan | 14.53 | 11.63 | 12.4 |
Novartis Ag has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Novartis Ag, about 15.2% more returns!
Aurinia Pharmaceuticals has performed better than Abbott Laboratories in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Xenetic Biosciences in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Vericel Corporation in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Savara Inc in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Staar Surgical in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Rocket Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Pacira Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Omeros Corporation in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Helius Medical in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Heron Therapeutics in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Genesis Healthcare in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Dermira Inc has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Dermira Inc, about 19.55% more returns!
Caredx Inc has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Caredx Inc, about 18.35% more returns!
Aurinia Pharmaceuticals has performed better than Ardelyx Inc in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Anixa Biosciences in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Acadia Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Arbutus Biopharma in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals Technical analysis of indicators
Price action analysis of Aurinia Pharmaceuticals (AUPH) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Aurinia Pharmaceuticals in short term and the sell signal is strong.
Aurinia Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aurinia Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.69 and Aurinia Pharmaceuticals AUPH stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aurinia Pharmaceuticals AUPH stock. Volume based technical analysis of Aurinia Pharmaceuticals AUPH stock is negative.
Aurinia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AUPH Aurinia Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AUPH Experts View which covers a lot of information including buying and selling signals
AUPH future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Aurinia Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


